Finance

Lists
Why is 0QF up ७.६१%?
Dive Deeper
0QF:FRA
Moderna Inc
€ १८०.१०
+७.६१%
(+१२.७४) 1D
अक्टोबर ५, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 0QF...
Open
€ १६९.७०
High
€ १८२.८२
Low
€ १६८.६२
Mkt. cap
८१.१३ अरब
Avg. vol.
१.७१ हजार
Volume
९१६.००
52-wk high
€ १८३.४०
52-wk low
€ १९.२६
No. of employees
५ हजार
Open
€ १६९.७०
High
€ १८२.८२
Low
€ १६८.६२
Mkt. cap
८१.१३ अरब
Avg. vol.
१.७१ हजार
Volume
९१६.००
52-wk high
€ १८३.४०
52-wk low
€ १९.२६
No. of employees
५ हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
३ घण्टा पहिले
Moderna stock gains as COO appointment meets Nasdaq-100 entry
Pluang
Pluang
·
४ घण्टा पहिले
Moderna stock jumps 8% ahead of full melanoma v...
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees४.७ हजार
Foundedसेप्टेम्बर २०१०
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.०२ अरब
६७.८० करोड
३८.९० करोड
१४.५० करोड
Cost of goods sold
१.०१ अरब
१.२३ अरब
७२.६० करोड
७३.८० करोड
Cost of revenue
१.०१ अरब
१.२३ अरब
७२.६० करोड
७३.८० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२६.८० करोड
३०.८० करोड
१७.३० करोड
२१.६० करोड
Operating expense
२६.८० करोड
३०.८० करोड
१७.३० करोड
२१.६० करोड
Total operating expenses
१.२८ अरब
१.५४ अरब
८९.९० करोड
९५.४० करोड
Operating income
-२६.०० करोड
-८५.७० करोड
-५१.०० करोड
-८०.९० करोड
Other non operating income
-४०.०० लाख
-२०.०० लाख
-
-२०.०० लाख
EBT including unusual items
-१८.७० करोड
-७९.९० करोड
-१.३३ अरब
-७६.७० करोड
EBT excluding unusual items
-१९.१० करोड
-७९.७० करोड
-४५.५० करोड
-७६.१० करोड
Income tax expense
१.३० करोड
२.७० करोड
९०.०० लाख
१.५० करोड
Effective tax rate
-६.९५%
-३.३८%
-०.६७%
-१.९६%
Other operating expenses
-
-
-
-
Net income
-२०.०० करोड
-८२.६० करोड
-१.३४ अरब
-७८.२० करोड
Net profit margin
-१९.६८%
-१२१.८३%
-३४५.२४%
-५३९.३१%
Earnings per share
-०.५१
-२.११
-३.४०
-१.९७
Interest and investment income
७.३० करोड
७.०० करोड
७.२० करोड
६.७० करोड
Interest expense
-
-८०.०० लाख
-१.७० करोड
-१.७० करोड
Net interest expenses
७.३० करोड
६.२० करोड
५.५० करोड
५.०० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-२०.८० करोड
-७९.०० करोड
-४५.१० करोड
-७४.६० करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू